Phase III
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once-Weekly Eloralintide versus Placebo in Adult Participants with Obesity who are on stable incretin background.
- Study IRB#:2000041604
- Last Updated:05/27/2026
Contact Us
For more information about this study, including how to volunteer, contact:
Sara Gesner
- Phone Number: 1-203-410-8509
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
